|
ZNF770 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.100430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.419800E-02 |
| Normal-vs-Stage2 |
3.064400E-02 |
| Normal-vs-Stage3 |
6.589000E-01 |
| Normal-vs-Stage4 |
9.544400E-01 |
| Stage1-vs-Stage2 |
1.450230E-01 |
| Stage1-vs-Stage3 |
2.080000E-01 |
| Stage1-vs-Stage4 |
2.006600E-01 |
| Stage2-vs-Stage3 |
5.441600E-02 |
| Stage2-vs-Stage4 |
3.942500E-02 |
| Stage3-vs-Stage4 |
6.644800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.497000E-01 |
| Normal-vs-AfricanAmerican |
3.071000E-01 |
| Normal-vs-Asian |
5.464800E-01 |
| Caucasian-vs-AfricanAmerican |
6.503400E-01 |
| Caucasian-vs-Asian |
8.740600E-01 |
| AfricanAmerican-vs-Asian |
5.781000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.860600E-01 |
| Normal-vs-Female |
8.372400E-02 |
| Male-vs-Female |
4.697800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.166760E-01 |
| Normal-vs-Age(41-60Yrs) |
2.780000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.877590E-01 |
| Normal-vs-Age(81-100Yrs) |
7.865000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.733800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.025000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.796600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.140600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.935200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.879000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.593700E-02 |
| Classical-VS-Follicular |
6.827900E-02 |
| Classical-VS-Other |
3.339600E-01 |
| Classical-VS-Normal |
1.035240E-01 |
| Tall-VS-Follicular |
2.363200E-03 |
| Tall-VS-Other |
9.662400E-01 |
| Tall-VS-Normal |
3.685000E-01 |
| Follicular-VS-Other |
1.661030E-01 |
| Follicular-VS-Normal |
8.318300E-03 |
| Other-VS-Normal |
5.701200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.303700E-02 |
| Normal-vs-N1 |
7.691400E-01 |
| N0-vs-N1 |
4.069600E-02 |
|
|
